Oramed Pharmaceuticals (NASDAQ:ORMP) Raised to Hold at StockNews.com
StockNews.com upgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Free Report) from a sell rating to a hold rating in a research note issued to investors on Thursday morning. Oramed Pharmaceuticals Stock Up 2.2 % Shares of Oramed Pharmaceuticals stock opened at $2.32 on Thursday. The business has a fifty day simple moving average of $2.25 […]
